Literature DB >> 32248390

Image Analysis of Eosinophil Peroxidase Immunohistochemistry for Diagnosis of Eosinophilic Esophagitis.

Benjamin L Wright1,2, Alfred D Doyle3, Kelly P Shim3,4, Rish K Pai5, Suzanne M Barshow3,4,6, Jennifer L Horsley-Silva7, Huijun Luo3, Matthew A Rank3,4, Elizabeth A Jacobsen3,8, David A Katzka9, Hirohito Kita3,8, Evan S Dellon10.   

Abstract

BACKGROUND: Diagnosis of eosinophilic esophagitis (EoE) requires manual quantification of tissue eosinophils. Eosinophil peroxidase (EPX) is an eosinophil-specific, cytoplasmic granule protein released during degranulation. AIMS: The objective of this study was to evaluate image analysis of EPX immunohistochemistry as an automated method for histologic diagnosis of EoE.
METHODS: We performed a secondary analysis of prospectively collected esophageal biopsies obtained from adult subjects with EoE and controls. Tissue sections were stained with hematoxylin and eosin (H&E) and evaluated for peak eosinophils per high power field (eos/hpf). The same slides were de-stained and re-stained to detect EPX for direct comparison. Slides were digitized, and EPX staining area/mm2 was quantified using image analysis. Paired samples were compared for changes in EPX staining in treatment responders and non-responders.
RESULTS: Thirty-eight EoE cases and 49 controls were analyzed. Among EoE subjects, matched post-treatment biopsies were available for 21 responders and 10 non-responders. Baseline EPX/mm2 was significantly increased in EoE subjects and decreased in treatment responders. EPX quantification correlated strongly with eos/hpf (r = 0.84, p < 0.0001) and identified EoE subjects with high diagnostic accuracy (AUC 0.95, p < 0.0001). The optimal diagnostic EPX-positive pixel/area threshold was 17,379 EPX/mm2. Several controls (5/49) with < 15 eos/hpf on H&E staining exceeded this cutoff.
CONCLUSIONS: EPX/mm2 correlates strongly with eos/hpf, accurately identifies subjects with EoE, and decreases in treatment responders. Automated quantification of intact eosinophils and their degranulation products may enhance pathologic assessment. Future studies are needed to correlate EPX/mm2 with symptoms, endoscopic findings, and esophageal distensibility.

Entities:  

Keywords:  Biomarker; Degranulation; Eosinophil peroxidase; Eosinophilic esophagitis; Image analysis

Mesh:

Substances:

Year:  2020        PMID: 32248390      PMCID: PMC7541435          DOI: 10.1007/s10620-020-06230-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  5 in total

1.  Extracellular Eosinophil Granule Protein Deposition in Ringed Esophagus with Sparse Eosinophils.

Authors:  Kathryn A Peterson; William J Cobell; Frederic C Clayton; Chaya Krishnamurthy; Jian Ying; Leonard F Pease; Hedieh Saffari; Ann Georgelas; John Fang; Gerald J Gleich; Kristin M Leiferman
Journal:  Dig Dis Sci       Date:  2015-04-23       Impact factor: 3.199

2.  Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring.

Authors:  M H Collins; L J Martin; E S Alexander; J Todd Boyd; R Sheridan; H He; S Pentiuk; P E Putnam; J P Abonia; V A Mukkada; J P Franciosi; M E Rothenberg
Journal:  Dis Esophagus       Date:  2017-02-01       Impact factor: 3.429

3.  Inter- and intraobserver reliability and validation of a new method for determination of eosinophil counts in patients with esophageal eosinophilia.

Authors:  Evan S Dellon; Karen J Fritchie; Tara C Rubinas; John T Woosley; Nicholas J Shaheen
Journal:  Dig Dis Sci       Date:  2009-10-15       Impact factor: 3.199

4.  Eosinophil infiltration in primary esophageal achalasia. A possible pathogenic role.

Authors:  A Tøttrup; K Fredens; P Funch-Jensen; S Aggestrup; R Dahl
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

5.  Persistent Basal Cell Hyperplasia Is Associated With Clinical and Endoscopic Findings in Patients With Histologically Inactive Eosinophilic Esophagitis.

Authors:  Kelly A Whelan; Bridget C Godwin; Benjamin Wilkins; Okan U Elci; Alain Benitez; Maureen DeMarshall; Medha Sharma; Jonathan Gross; Andres J Klein-Szanto; Chris A Liacouras; Evan S Dellon; Jonathan M Spergel; Gary W Falk; Amanda B Muir; Hiroshi Nakagawa
Journal:  Clin Gastroenterol Hepatol       Date:  2019-09-06       Impact factor: 11.382

  5 in total
  4 in total

Review 1.  Solving the Conundrum of Eosinophils in Alloimmunity.

Authors:  Cherie Alissa Lynch; Yizhan Guo; Zhongcheng Mei; Daniel Kreisel; Andrew E Gelman; Elizabeth A Jacobsen; Alexander Sasha Krupnick
Journal:  Transplantation       Date:  2021-12-27       Impact factor: 5.385

Review 2.  Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions.

Authors:  Alfred D Doyle; Mia Y Masuda; Hirohito Kita; Benjamin L Wright
Journal:  Front Immunol       Date:  2020-12-01       Impact factor: 7.561

Review 3.  Non-invasive biomarkers of eosinophilic esophagitis.

Authors:  Martina Votto; Maria De Filippo; Riccardo Castagnoli; Francesco Delle Cave; Francesca Giffoni; Viola Santi; Marta Vergani; Carlo Caffarelli; Mara De Amici; Gian Luigi Marseglia; Amelia Licari
Journal:  Acta Biomed       Date:  2021-11-29

4.  Diagnosis of Pediatric Non-Esophageal Eosinophilic Gastrointestinal Disorders by Eosinophil Peroxidase Immunohistochemistry.

Authors:  Shaina H Hasan; Steve Taylor; Shipra Garg; Matthew R Buras; Alfred D Doyle; Cindy S Bauer; Benjamin L Wright; Shauna Schroeder
Journal:  Pediatr Dev Pathol       Date:  2021-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.